A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Clinical trial NCT06789289 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06789289
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-17
- Primary completion
- 2027-03-17
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.